참고문헌
- Hoffman, M. M. and Monroe, D. M. (2005) Rethinking the coagulation cascade. Curr. Hematol. Rep. 4, 391-396.
- Davie, E. W., Fujikawa, K. and Kisiel, W. (1991) The coagulation cascade: initiation, maintenance, and regulation. Biochemistry. 30, 10363-10370. https://doi.org/10.1021/bi00107a001
- Davie, E. W. (1995) Biochemical and molecular aspects of the coagulation cascade. Thromb. Haemost. 74, 1-6.
- Esmon, C. T. (2001) Role of coagulation inhibitors in inflammation. Thromb. Haemost. 86, 51-56.
- Quinn, C., Hill, J. and Hassouna, H. (2000) A guide for diagnosis of patients with arterial and venous thrombosis. Clin. Lab. Sci. 13, 229-238.
- Levi, M., Schultz, M. and van der Poll, T. (2011) Coagulation biomarkers in critically ill patients. Crit. Care Clin. 27, 281-297. https://doi.org/10.1016/j.ccc.2010.12.009
- Abou-Karam, M. and Shier, W. T. (1999) Inhibition of oncogene product enzyme activity as an approach to cancer chemoprevention. Tyrosine-specific protein kinase inhibition by purpurogallin from Quercus sp. nutgall. Phytother. Res. 13, 337-340. https://doi.org/10.1002/(SICI)1099-1573(199906)13:4<337::AID-PTR451>3.0.CO;2-J
- Das, M., Bickers, D. R. and Mukhtar, H. (1984) Plant phenols as in vitro inhibitors of glutathione S-transferase(s). Biochem. Biophys. Res. Commun. 120, 427-433. https://doi.org/10.1016/0006-291X(84)91271-3
- Zeng, L. H. and Wu, T. W. (1992) Purpurogallin is a more powerful protector of kidney cells than Trolox and allopurinol. Biochem. Cell Biol. 70, 684-690. https://doi.org/10.1139/o92-104
- Veser, J. (1987) Kinetics and inhibition studies of catechol O-methyltransferase from the yeast Candida tropicalis. J. Bacteriol. 169, 3696-3700. https://doi.org/10.1128/jb.169.8.3696-3700.1987
- Wu, T. W., Zeng, L. H., Wu, J. and Carey, D. (1991) Purpurogallin--a natural and effective hepatoprotector in vitro and in vivo. Biochem. Cell Biol. 69, 747-750. https://doi.org/10.1139/o91-113
- Wu, T. W., Zeng, L. H., Wu, J., Fung, K. P., Weisel, R. D., Hempel, A. and Camerman, N. (1996) Molecular structure and antioxidant specificity of purpurogallin in three types of human cardiovascular cells. Biochem. Pharmacol. 52, 1073-1080. https://doi.org/10.1016/0006-2952(96)00447-9
- Inamori, Y., Muro, C., Sajima, E., Katagiri, M., Okamoto, Y., Tanaka, H., Sakagami, Y. and Tsujibo, H. (1997) Biological activity of purpurogallin. Biosci. Biotechnol. Biochem. 61, 890-892. https://doi.org/10.1271/bbb.61.890
- Kim, T. H., Ku, S. K., Lee, I. C. and Bae, J. S. (2012) Anti-inflammatory functions of purpurogallin in LPS-activated human endothelial cells. BMB Rep. 45, 200-205. https://doi.org/10.5483/BMBRep.2012.45.3.200
- Esmon, C. T. (2005) The interactions between inflammation and coagulation. Br. J. Haematol. 131, 417-430. https://doi.org/10.1111/j.1365-2141.2005.05753.x
- Sugo, T., Nakamikawa, C., Tanabe, S. and Matsuda, M. (1995) Activation of prothrombin by factor Xa bound to the membrane surface of human umbilical vein endothelial cells: its catalytic efficiency is similar to that of prothrombinase complex on platelets. J. Biochem. 117, 244-250. https://doi.org/10.1093/jb/117.2.244
- Rao, L. V., Rapaport, S. I. and Lorenzi, M. (1988) Enhancement by human umbilical vein endothelial cells of factor Xa-catalyzed activation of factor VII. Blood 71, 791-796.
- Ghosh, S., Ezban, M., Persson, E., Pendurthi, U., Hedner, U. and Rao, L. V. (2007) Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface. J. Thromb. Haemost. 5, 336-346. https://doi.org/10.1111/j.1538-7836.2007.02308.x
- Philip-Joet, F., Alessi, M. C., Philip-Joet, C., Aillaud, M., Barriere, J. R., Arnaud, A. and Juhan-Vague, I. (1995) Fibrinolytic and inflammatory processes in pleural effusions. Eur. Respir. J. 8, 1352-1356. https://doi.org/10.1183/09031936.95.08081352
- Schleef, R. R., Bevilacqua, M. P., Sawdey, M., Gimbrone, M. A., Jr. and Loskutoff, D. J. (1988) Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J. Biol. Chem. 263, 5797-5803.
- Hamaguchi, E., Takamura, T., Shimizu, A. and Nagai, Y. (2003) Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells. J. Pharmacol. Exp. Ther. 307, 987-994. https://doi.org/10.1124/jpet.103.054346
- Lopez, S., Peiretti, F., Bonardo, B., Juhan-Vague, I. and Nalbone, G. (2000) Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells. Atherosclerosis 152, 359-366. https://doi.org/10.1016/S0021-9150(00)00454-8
- Schouten, M., Wiersinga, W. J., Levi, M. and van der Poll, T. (2008) Inflammation, endothelium, and coagulation in sepsis. J. Leukoc. Biol. 83, 536-545. https://doi.org/10.1189/jlb.0607373
- Kim, T. H., Ku, S. K. and Bae, J. S. (2012) Antithrombotic and profibrinolytic activities of eckol and dieckol. J. Cell Biochem. 113, 2877-2883. https://doi.org/10.1002/jcb.24163
- Kim, S. Y., Kim, S., Kim, J. M., Jho, E. H., Park, S., Oh, D. and Yun-Choi, H. S. (2011) PKC inhibitors RO 31-8220 and Go 6983 enhance epinephrine-induced platelet aggregation in catecholamine hypo-responsive platelets by enhancing Akt phosphorylation. BMB Rep. 44, 140-145. https://doi.org/10.5483/BMBRep.2011.44.2.140
- Nowak, P., Zbikowska, H. M., Ponczek, M., Kolodziejczyk, J. and Wachowicz, B. (2007) Different vulnerability of fibrinogen subunits to oxidative/nitrative modifications induced by peroxynitrite: functional consequences. Thromb. Res. 121, 163-174. https://doi.org/10.1016/j.thromres.2007.03.017
- Bae, J. S. and Rezaie, A. R. (2008) Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb Haemost 100, 101-109.
- Bae, J. S. (2011) Antithrombotic and profibrinolytic activities of phloroglucinol. Food Chem. Toxicol. 49, 1572-1577. https://doi.org/10.1016/j.fct.2011.04.003
- Dejana, E., Callioni, A., Quintana, A. and de Gaetano, G. (1979) Bleeding time in laboratory animals. II - A comparison of different assay conditions in rats. Thromb. Res. 15, 191-197. https://doi.org/10.1016/0049-3848(79)90064-1
피인용 문헌
- PEGylated lysozymes with anti-septic effects in human endothelial cells and in mice vol.459, pp.4, 2015, https://doi.org/10.1016/j.bbrc.2015.02.167
- Ameliorative effect of a rarely occurring C-methylrotenoid on HMGB1-induced septic responses in vitro and in vivo vol.110-111, 2016, https://doi.org/10.1016/j.bcp.2016.04.006
- Suppressive effects of pelargonidin on PolyPhosphate-mediated vascular inflammatory responses vol.40, pp.2, 2017, https://doi.org/10.1007/s12272-016-0856-z
- Antithrombotic and antiplatelet activities of orientin in vitro and in vivo vol.17, 2015, https://doi.org/10.1016/j.jff.2015.05.037
- Suppressive effects of three diketopiperazines from marine-derived bacteria on TGFBIp-mediated septic responses in human endothelial cells and mice vol.39, pp.6, 2016, https://doi.org/10.1007/s12272-016-0743-7
- Antiseptic Effects of New 3′-N-Substituted Carbazole Derivatives In Vitro and In Vivo vol.38, pp.4, 2015, https://doi.org/10.1007/s10753-015-0141-1
- Methylthiouracil, a new treatment option for sepsis vol.88, 2017, https://doi.org/10.1016/j.vph.2015.07.013
- Antitcoagulant and antiplatelet activities of scolymoside vol.48, pp.10, 2015, https://doi.org/10.5483/BMBRep.2015.48.10.044
- Inhibitory effects of three diketopiperazines from marine-derived bacteria on endothelial protein C receptor shedding in human endothelial cells and mice vol.110, 2016, https://doi.org/10.1016/j.fitote.2016.03.016
- Antithrombotic and antiplatelet activities of small-molecule alkaloids from Scolopendra subspinipes mutilans vol.6, pp.1, 2016, https://doi.org/10.1038/srep21956
- Inhibitory effect of exendin-4 on secretory group IIA phospholipase A2 vol.459, pp.4, 2015, https://doi.org/10.1016/j.bbrc.2015.02.165
- Inhibitory effects of polyozellin from Polyozellus multiplex on HMGB1-mediated septic responses vol.64, pp.9, 2015, https://doi.org/10.1007/s00011-015-0856-3
- Anti-inflammatory effects of methylthiouracil in vitro and in vivo vol.288, pp.3, 2015, https://doi.org/10.1016/j.taap.2015.08.009
- Anti-Inflammatory Effects of Lysozyme Against HMGB1 in Human Endothelial Cells and in Mice vol.38, pp.5, 2015, https://doi.org/10.1007/s10753-015-0171-8
- Antithrombotic and antiplatelet activities of vicenin-2 vol.26, pp.6, 2015, https://doi.org/10.1097/MBC.0000000000000320
- Antithrombotic and antiplatelet activities of pelargonidin in vivo and in vitro vol.39, pp.3, 2016, https://doi.org/10.1007/s12272-016-0708-x
- Ameliorative Effect of Vicenin-2 and Scolymoside on TGFBIp-Induced Septic Responses vol.38, pp.6, 2015, https://doi.org/10.1007/s10753-015-0199-9
- Inhibitory effect of polyozellin on secretory group IIA phospholipase A2 vol.39, pp.2, 2016, https://doi.org/10.1007/s12272-015-0694-4
- Vascular barrier protective effects of 3-N- or 3-O-cinnamoyl carbazole derivatives vol.25, pp.19, 2015, https://doi.org/10.1016/j.bmcl.2015.07.079
- Inhibitory effects of pentacyclic triterpenoids from Astilbe rivularis on TGFBIp-induced inflammatory responses in vitro and in vivo vol.254, 2016, https://doi.org/10.1016/j.cbi.2016.06.015
- Bioconversion of Biomass-Derived Phenols Catalyzed by Myceliophthora thermophila Laccase vol.21, pp.5, 2016, https://doi.org/10.3390/molecules21050550
- Anti-inflammatory effects of pelargonidin on TGFBIp-induced responses vol.95, pp.4, 2017, https://doi.org/10.1139/cjpp-2016-0322
- In-depth proteomics approach of secretome to identify novel biomarker for sepsis in LPS-stimulated endothelial cells vol.36, pp.23, 2015, https://doi.org/10.1002/elps.201500198